Alzheimer's disease

No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 Months
BioSpace
Thu, 02/8/24 - 10:57 am
Cassava Sciences
Alzheimer's disease
clinical trials
simufilam
Eisai, Biogen likely to miss early launch goal for Alzheimer's drug Leqembi
Fierce Pharma
Wed, 02/7/24 - 11:33 am
Eisai
Biogen
FDA
Medicare
Leqembi
Alzheimer's disease
Biogen abandons Aduhelm efforts, focuses on Eisai-partnered Leqembi and pipeline drugs
Fierce Pharma
Wed, 01/31/24 - 11:50 am
Biogen
Aduhelm
Leqembi
Alzheimer's disease
FDA lifts clinical hold on INmune Bio’s Phase II Alzheimer’s trial
Clinical Trials Arena
Tue, 01/30/24 - 09:19 pm
INmune Bio
clinical trials
Alzheimer's disease
Xpro
FDA
Silo Pharma’s ketamine-based drug for Alzheimer’s effective against dementia symptoms in mice
Fierce Biotech
Fri, 01/26/24 - 12:02 pm
Silo Pharma
ketamine
Alzheimer's disease
SPC-14
Trial raises hopes for simple Alzheimer’s blood test
Pharmaphorum
Tue, 01/23/24 - 10:56 am
ALZpath
diagnostics
Medtech
Alzheimer's disease
EU regulators to consult advisers in review of Eisai Alzheimer’s drug
BioPharma Dive
Thu, 01/11/24 - 08:40 pm
Eisai
Leqembi
Europe
Alzheimer's disease
Biogen CEO sees progress in launch of Alzheimer’s drug Leqembi
BioPharma Dive
Mon, 01/8/24 - 10:22 pm
Biogen
Pharma CEOs
Chris Viehbacher
Leqembi
Alzheimer's disease
insurance
JPMHC 2024
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
CP Wire
Wed, 11/22/23 - 12:46 pm
Alzheimer's disease
simulation
drug discovery
SIAM News
Duke University
Penn State University
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Wed, 11/22/23 - 12:17 pm
Alzheimer's disease
simulation
drug discovery
SIAM News
Duke University
Penn State University
A year after Roche's Alzheimer's failure, scientists reflect on what could have been
Fierce Biotech
Wed, 11/15/23 - 11:49 pm
Roche
Genentech
Alzheimer's disease
gantenerumab
Biogen's M&A, Alzheimer's drug launch costs spark profit forecast cut
Reuters
Wed, 11/8/23 - 11:35 am
Biogen
Alzheimer's disease
Leqembi
Reata
M&A
earnings
Eisai expects Alzheimer's drug to rake in revenue of $66.5 million by March
Reuters
Tue, 11/7/23 - 09:57 am
Eisai
Leqembi
Alzheimer's disease
Co-developer of Cassava’s potential Alzheimer’s drug cited for ‘egregious misconduct’
Science
Mon, 10/30/23 - 08:15 pm
Cassava Sciences
Alzheimer's disease
Simulfilam
clinical trials
Doubts abound about a new Alzheimer’s blood test
Medical Marketing and Media
Fri, 10/27/23 - 11:31 am
diagnostics
Quest Diagnostics
Medtech
Alzheimer's disease
AD-Detect
Merck terminates Phase II trials for Alzheimer’s drug due to liver toxicity
Clinical Trials Arena
Thu, 10/26/23 - 11:53 am
Merck
clinical trials
MK-1942
liver toxicity
Alzheimer's disease
Eisai says new data could support more convenient form of Alzheimer’s drug Leqembi
BioPharma Dive
Wed, 10/25/23 - 10:42 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
Araclon vaccine appears to slow Alzheimer's in exploratory phase 2 analysis, spurring review of next steps
Fierce Biotech
Wed, 10/25/23 - 09:56 am
Araclon
Grifols
Alzheimer's disease
clinical trials
vaccines
ABvac40
CuraSen to bring new Alzheimer’s drug into trial in 2024
Clinical Trials Arena
Wed, 10/18/23 - 10:05 am
CuraSen Therapeutics
clinical trials
CST-3056
Alzheimer's disease
As 'harvest time' arrives for Alzheimer's, neuroscientist reflects on next steps for drug development
Fierce Biotech
Mon, 10/16/23 - 10:12 am
Alzheimer's disease
Biogen
Eisai
Eli Lilly
Leqembi
donanemab

Pages